AI Watch: SoftBank's $40B OpenAI Bet, Lilly's $2.75B AI Drug Deal, Grok's EU Setback

• SoftBank secured a $40 billion short-term loan to increase its investment in OpenAI, hinting at a potential IPO.
• Eli Lilly finalized a $2.75 billion agreement with Insilico Medicine for the global commercialization of AI-developed drugs.
• Elon Musk's Grok is encountering legal challenges in Europe due to concerns over the misuse of AI-generated imagery.
• India's Sarvam AI introduced Chanakya, an AI model designed for secure government deployments.